Open-Label Study of the Efficacy, Safety, and Durability of Peanut Sublingual Immunotherapy in Peanut-Allergic Children. Sacta MA, Brown-Whitehorn T. Pediatrics 2023;152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sacta MA, Brown-Whitehorn T. Open-Label Study of the Efficacy, Safety, and Durability of Peanut Sublingual Immunotherapy in Peanut-Allergic Children. Pediatrics 2023;152.
PMID: 38038544